Beta-blockers in cirrhosis: Friend and foe?

Developments and controversies in the management of oesophageal and gastric varices

(2010) G. Mehta et al.   GUT

Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites

(2010) Thomas Sersté et al.   HEPATOLOGY

Management of Varices and Variceal Hemorrhage in Cirrhosis

(2010) Guadalupe Garcia-Tsao et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Use of E/A Ratio as a Predictor of Outcome in Cirrhotic Patients Treated With Transjugular Intrahepatic Portosystemic Shunt

(2009) Rania Nancy Rabie et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites

(2009) A Krag et al.   GUT

β-Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis

(2009) Marco Senzolo et al.   LIVER INTERNATIONAL

Cirrhotic cardiomyopathy

(2008) Florence Wong   Hepatology International